Literature DB >> 15405697

The effect of 8-azaguanine on the growth of carcinoma, sarcoma, osteogenic sarcoma, lymphosarcoma and melanoma in animals.

K SUGIURA, G H HITCHINGS.   

Abstract

Entities:  

Keywords:  CANCER; SARCOMA

Mesh:

Substances:

Year:  1950        PMID: 15405697

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejection.

Authors:  Casey W Shuptrine; Reham Ajina; Elana J Fertig; Sandra A Jablonski; H Kim Lyerly; Zachary C Hartman; Louis M Weiner
Journal:  Cancer Immunol Immunother       Date:  2017-08-02       Impact factor: 6.968

2.  The metabolism of 8-azapurines.

Authors:  J D SMITH; R E MATTHEWS
Journal:  Biochem J       Date:  1957-06       Impact factor: 3.857

3.  Problems in the Designing of Antimetabolites.

Authors:  H G Mautner
Journal:  Yale J Biol Med       Date:  1960-04

4.  Pharmacological and Predicted Activities of Natural Azo Compounds.

Authors:  Valery M Dembitsky; Tatyana A Gloriozova; Vladimir V Poroikov
Journal:  Nat Prod Bioprospect       Date:  2017-01-04

5.  Revisiting Connectivity Map from a gene co-expression network analysis.

Authors:  Wei Liu; Wei Tu; Li Li; Yingfu Liu; Shaobo Wang; Ling Li; Huan Tao; Huaqin He
Journal:  Exp Ther Med       Date:  2018-06-08       Impact factor: 2.447

6.  Construction of a novel prognostic-predicting model correlated to ovarian cancer.

Authors:  Weichun Tang; Jie Li; Xinxia Chang; Lizhou Jia; Qi Tang; Ying Wang; Yanli Zheng; Lizhou Sun; Zhenqing Feng
Journal:  Biosci Rep       Date:  2020-08-28       Impact factor: 3.840

7.  Effect of adenosine-5-phosphoric acid, adenosine-3-phosphoric acid and adenosine triphosphate on the growth of Ehrlich carcinoma.

Authors:  C M AMBRUS; J L AMBRUS; J W E HARRISSON; H CRAVETZ
Journal:  Br J Cancer       Date:  1951-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.